What's New at CBER

You are subscribed to  What's New at CBER for the U.S. Food & Drug Administration (FDA)

What's New Today

The following links have been updated recently:

Posted: 3/11/2024

• February 28, 2024 Summary Basis for Regulatory Action - Elecsys Anti-HCV II
• Blood Products Advisory Committee May 9, 2024 Meeting Announcement
• CBER Title 21 Vacancy Announcement – Lead Program Analyst, Band C, Center for Biologics Evaluation and Research (CBER), Office of Management (OM), Division of Management and Planning Analysis (DMPA), Capacity Planning and Management Analysis Branch (CPMAB)

Workshops, Meetings & Conferences

May

• Vaccines and Related Biological Products Advisory Committee Meeting
  May 16, 2024